Difficulty: Medium
Average Score: 75%
Practice
A client is receiving treatment with capecitabine. Which of the following findings should the nurse monitor?
Correct answer
C
Rationale
In pharmacology, understanding the side effects and monitoring parameters for specific medications is crucial for safe and effective patient care. In the case of capecitabine, a chemotherapy medication, the nurse should monitor for neutropenia. Neutropenia is a common side effect of chemotherapy drugs like capecitabine, which suppress bone marrow function, leading to a decrease in neutrophils, an essential type of white blood cell responsible for fighting infections.
Option A, hyperglycemia, is not typically associated with capecitabine and is more commonly seen with medications like corticosteroids or certain antipsychotics. Option B, hypocalcemia, is not a known side effect of capecitabine but may occur with medications that affect calcium metabolism or parathyroid function. Option D, bradycardia, is not a common side effect of capecitabine but may be seen with medications that affect cardiac conduction.
Understanding the specific side effects of medications helps nurses provide comprehensive care by monitoring for and managing potential complications. In oncology, monitoring for neutropenia is crucial to prevent infections and ensure patient safety during cancer treatment.
Option A, hyperglycemia, is not typically associated with capecitabine and is more commonly seen with medications like corticosteroids or certain antipsychotics. Option B, hypocalcemia, is not a known side effect of capecitabine but may occur with medications that affect calcium metabolism or parathyroid function. Option D, bradycardia, is not a common side effect of capecitabine but may be seen with medications that affect cardiac conduction.
Understanding the specific side effects of medications helps nurses provide comprehensive care by monitoring for and managing potential complications. In oncology, monitoring for neutropenia is crucial to prevent infections and ensure patient safety during cancer treatment.